Quality of life measures in lung cancer.
Lung cancer is one of the leading causes of cancer death worldwide. Survival has not improved significantly in spite of newer therapies. In view of the high-symptom burden and severe morbidity, evaluation of quality of life (QOL) becomes important in these patients. Several instruments are now available for this purpose, and have demonstrated good correlation with performance status, symptoms, and survival. Quality of life assessments also help in comparing different therapeutic regimes, thus allowing selection of the appropriate modality. Problems of inconsistent interpretability and high-patient dropout rate poses a challenging problem that needs to be tackled. In spite of these drawbacks, QOL is now considered to be an essential component of lung cancer management and should be performed routinely. Such a practice will help the physician plan appropriate treatment strategies and set practical therapeutic goals.
Anant
Mohan
M
Department of Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029, India.
Guleria
Randeep
R
Pathak
Ashutosh K
AK
Bhutani
Manisha
M
Pal
Hemraj
H
Charu
Mohan
M
Kochupillai
V
V
D001294:Attitude to Health; D006801:Humans; D008175:Lung Neoplasms / Q000503:physiopathology / Q000523:psychology*; D011379:Prognosis; D011594:Psychometrics / Q000295:instrumentation*; D011788:Quality of Life; D018570:Risk Assessment; D018434:Sickness Impact Profile; D011795:Surveys and Questionnaires